ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 355457 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 355457; 2) Community: the network communities that were significantly associated with the response to NSC 355457; 3) Molecule: the relationships between components within communities and NSC 355457; 4) MDR: the compounds that were significantly associated with the NSC 355457.

NSC Compound Enrichment Correlation
NSC 36525 8-[(4-tert-butylphenoxy)methyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione 0.00334162892839397 0.054752829
NSC 670121 11-Hydroxy aclacinomycin A 0.00334162892839397 0.24971435
NSC 686554 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(2-pyridinyl)- 0.00334162892839397 0.54771199
NSC 694509 Null 0.00334162892839397 0.39456765
NSC 727620 6-[3-(2-Aminoethylamino)]-bis{1-propyl)-5,6-dihydro-2,3-dime thoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquin oline} dihydrochloride 0.00334162892839397 0.52876835
NSC 733476 Null 0.00334162892839397 0.1061831
NSC 711074 Null 0.00336064452966826 0.079453278
NSC 681634 Camptothecin Derivative 0.00336064452966832 0.67734175
NSC 683557 Camptothecin Derivative 0.00336064452966832 0.72455779
NSC 689534 Hydrazinecarbothioamide, N,N-bis[(2-pyridinyl)methyl]-2-[(2-pyridinyl)methylene]- 0.00336064452966832 0.33926186
Total:69  Current:4    [First] [Prev] [Next] [Last]